Reviewing the Role of VEGF-Targeting Agents in the Treatment of GI Cancers

Table of Contents

 
  • Program Overview
    Reviewing the Role of VEGF-Targeting Agents in the Treatment of GI Cancers
    In this CME-certified educational activity, an expert panel comprising Jordi Bruix, MD; Yelena Y. Janjigian , MD; John L. Marshall, MD; and Neeta Somaiah, MD, discuss the most recent clinical data informing the optimal use of VEGF-targeted therapies in the care of patients with advanced CRC, HCC, gastric/GEJ cancer, and GIST.
  • Featured content
    Get the most recent clinical data informing the optimal use of VEGF-targeted therapies in colorectal cancer, gastric and GEJ cancer, HCC, and GIST.
  • 1
  • 2

Latest Content

2 of 2 Shown
2 of 2 Shown
Show 0 More
Loading...